Potential of hybrid 18F-fluorocholine PET/MRI for prostate cancer imaging

被引：0
作者：
Thomas de Perrot
Olivier Rager
Max Scheffler
Martin Lord
Marc Pusztaszeri
Christophe Iselin
Osman Ratib
Jean-Paul Vallee
机构：
[1] Geneva University Hospitals and University of Geneva,Division of Radiology
[2] Geneva University Hospitals,Division of Nuclear Medicine
[3] University of Montreal Hospital Center,Division of Nuclear Medicine
[4] Geneva University Hospitals,Division of Clinical Pathology
[5] Geneva University Hospitals,Division of Urologic Surgery
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2014年 / 41卷
关键词：
Prostate; Cancer; PET/MRI; F-Fluorocholine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1744 / 1755
页数：11
相关论文
共 50 条
  • [41] The role of [18F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer
    Dias, Adriano Basso
    Mirshahvalad, Seyed Ali
    Ortega, Claudia
    Perlis, Nathan
    Berlin, Alejandro
    van der Kwast, Theodorus
    Ghai, Sangeet
    Jhaveri, Kartik
    Metser, Ur
    Haider, Masoom
    Avery, Lisa
    Veit-Haibach, Patrick
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (07) : 2167 - 2176
  • [42] 18F-choline PET/MRI on initial staging of prostate cancer. Impact on therapy approach
    Garcia, J. R.
    Compte, A.
    Galan, C.
    Cozar, M.
    Buxeda, M.
    Mourelo, S.
    Pineiro, T.
    Soler, M.
    Valls, E.
    Bassa, P.
    Santabarbara, J. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2021, 40 (02): : 72 - 81
  • [43] Hybrid PET/MRI Imaging of 18F-Fluorodeoxyglucose and 18-kDa Translocator Protein for Presurgical Localization in Refractory Epilepsy
    Zhang, Siqi
    Hu, Jie
    Qi, Zhigang
    Yao, Chenyang
    Cui, Bixiao
    Wang, Jingjuan
    Wang, Zhenming
    Lu, Jie
    CNS NEUROSCIENCE & THERAPEUTICS, 2025, 31 (02)
  • [44] [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer
    Vrachimis, Alexis
    Burg, Matthias Christian
    Wenning, Christian
    Allkemper, Thomas
    Weckesser, Matthias
    Schaefers, Michael
    Stegger, Lars
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (02) : 212 - 220
  • [45] [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer
    Alexis Vrachimis
    Matthias Christian Burg
    Christian Wenning
    Thomas Allkemper
    Matthias Weckesser
    Michael Schäfers
    Lars Stegger
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 212 - 220
  • [46] A PET/MRI study towards finding the optimal [18F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancer
    Mattijs Elschot
    Kirsten M. Selnæs
    Elise Sandsmark
    Brage Krüger-Stokke
    Øystein Størkersen
    May-Britt Tessem
    Siver A. Moestue
    Helena Bertilsson
    Tone F. Bathen
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 695 - 703
  • [47] A PET/MRI study towards finding the optimal [18F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancer
    Elschot, Mattijs
    Selnaes, Kirsten M.
    Sandsmark, Elise
    Kruger-Stokke, Brage
    Storkersen, Oystein
    Tessem, May-Britt
    Moestue, Siver A.
    Bertilsson, Helena
    Bathen, Tone F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (04) : 695 - 703
  • [48] Chordoma: 18F-FDG PET/CT and MRI imaging features
    Joshua T. Olson
    Doris E. Wenger
    Peter S. Rose
    Ivy A. Petersen
    Stephen M. Broski
    Skeletal Radiology, 2021, 50 : 1657 - 1666
  • [49] [18F]FDG-PET/CT and MRI for initial pelvic lymph node staging in patients with cervical carcinoma: The potential usefulness of [18F]FDG-PET/MRI
    Anner, Philip
    Mayerhoefer, Marius
    Wadsak, Wolfgang
    Geleff, Silvana
    Dudczak, Robert
    Haug, Alexander
    Hacker, Marcus
    Karanikas, Georgios
    ONCOLOGY LETTERS, 2018, 15 (03) : 3951 - 3956
  • [50] Comparison of [18F]fluorocholine and [18F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer
    Price, DT
    Coleman, RE
    Liao, RP
    Robertson, CN
    Polascik, TJ
    deGrado, TR
    JOURNAL OF UROLOGY, 2002, 168 (01) : 273 - 280
12345